A single question for the rapid screening of restless legs syndrome in the neurological clinical practice
✍ Scribed by R. Ferri; B. Lanuzza; F. I. I. Cosentino; I. Iero; M. Tripodi; R. S. Spada; G. Toscano; S. Marelli; D. Aricò; R. Bella; W. A. Hening; M. Zucconi
- Book ID
- 111065213
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 563 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1351-5101
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot
The Restless Legs Syndrome (RLS) is a sensorimotor disorder that has only recently been extensively investigated by validated methods. Following the first presentation of diagnostic criteria by the International RLS Study Group in 1995, several methods were specifically developed for clinical trials